Eton Pharmaceuticals, Inc.
ETON
$17.29
-$0.17-0.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.52% | 48.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.52% | 48.38% | |||
| Cost of Revenue | -21.88% | 43.51% | |||
| Gross Profit | 33.16% | 52.27% | |||
| SG&A Expenses | 5.64% | 45.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.13% | 67.42% | |||
| Operating Income | 42.98% | -145.02% | |||
| Income Before Tax | -68.16% | -193.15% | |||
| Income Tax Expenses | -10.81% | -14.94% | |||
| Earnings from Continuing Operations | -64.44% | -162.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -64.44% | -162.88% | |||
| EBIT | 42.98% | -145.02% | |||
| EBITDA | 35.73% | -59.14% | |||
| EPS Basic | -64.27% | -155.46% | |||
| Normalized Basic EPS | 12.36% | -1,413.04% | |||
| EPS Diluted | -70.94% | -110.43% | |||
| Normalized Diluted EPS | 12.36% | -1,413.04% | |||
| Average Basic Shares Outstanding | 0.02% | 2.87% | |||
| Average Diluted Shares Outstanding | 0.02% | 2.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||